Clinical Trial

Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome

Recruiting
View on ClinicalTrials.gov →
Summary
This retrospective cohort study evaluates the association between H. pylori persistence and insulin resistance severity (HOMA-IR) in 100 patients with metabolic syndrome at Novosibirsk's Center for New Medical Technologies (CNMT). Patients are divided into infected (n=50) and non-infected (n=50) groups, assessing metabolic parameters, gastro panel, and CRP. Primary endpoint: HOMA-IR differences; secondary: correlations with gastric inflammation and metabolic markers.
Trial Details
NCT Number NCT07501858
Lead Sponsor Center of New Medical Technologies
Collaborators: Novosibirsk State University
Conditions Metabolic Syndrome
Enrollment 100 participants
Start Date 2026-04-01
Primary Completion 2028-04-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-30